Rankings
▼
Calendar
ARGX Q4 2020 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$46B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$23M
-27.6% YoY
Gross Profit
-$126M
-556.7% margin
Operating Income
-$209M
-924.4% margin
Net Income
-$313M
-1380.7% margin
EPS (Diluted)
$-6.60
Cash Flow
Operating Cash Flow
-$204M
Free Cash Flow
-$204M
Stock-Based Comp.
$47M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$23M
$31M
-27.6%
Gross Profit
-$126M
-$88M
-43.1%
Operating Income
-$209M
-$124M
-68.7%
Net Income
-$313M
-$118M
-165.3%
← Q2 2020
All Quarters
Q2 2021 →